Penumbra Inc. (PEN)
NYSE
Closed
Oct 8, 2026
Day's Range
316.5352 wk Range
221.26Overview - PEN - Penumbra Inc.
Key Statistics
Valuation
Enterprise Value
12.04B
P/E (Trailing)
‪77.89‬
P/E (Forward)
‪51.70‬
PEG Ratio
‪-3.31‬
Price / Sales (TTM)
‪8.29‬
Price / Book
‪8.15‬
EV / EBITDA
‪58.95‬
Profitability
Gross Margin
‪67.92%‬
Profit Margin
‪10.67%‬
Operating Margin
‪10.52%‬
Return on Assets
‪6.41%‬
Return on Equity
‪11.37%‬
Ownership
Shares Outstanding
39.38M
Float
38.27M
Short % of Shares Outstanding
‪5.26%‬
Held by Insiders
‪2.89%‬
Held by Institutions
‪88.33%‬
Price stats
Beta
‪0.70‬
50-Day Avg
‪321.59‬
200-Day Avg
‪326.88‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
16 analysts
Average price target
‪$ 361.83‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PEN - Penumbra Inc.
Peers - PEN - Penumbra Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
- PENNYSEPenumbra Inc.12.48BMarket Cap+18.32%52-week change77.90P/E (Trailing)‪10.67%‬Profit Margin
- CVXNYSEChevron Corporation406.24BMarket Cap+25.86%52-week change19.95P/E (Trailing)‪9.83%‬Profit Margin
- ABTNYSEAbbott Laboratories169.82BMarket Cap-37.17%52-week change31.55P/E (Trailing)‪11.64%‬Profit Margin
- MDTNYSEMedtronic plc110.49BMarket Cap-13.95%52-week change21.28P/E (Trailing)‪13.93%‬Profit Margin
- SYKNYSEStryker Corp.105.64BMarket Cap-32.98%52-week change28.32P/E (Trailing)‪14.43%‬Profit Margin
- ICENYSEIntercontinental Exchange, Inc.84.29BMarket Cap-5.93%52-week change21.39P/E (Trailing)‪38.24%‬Profit Margin
- BSXNYSEBoston Scientific Corp.61.73BMarket Cap-127.00%52-week change17.25P/E (Trailing)‪17.49%‬Profit Margin
Profile Summary - PEN - Penumbra Inc.
About
Penumbra Inc. is a medical device company that designs, develops, manufactures, and markets products for interventional therapies in vascular and neurological care. Its portfolio centers on thrombectomy systems used to remove blood clots, including solutions for peripheral and neurovascular applications, along with…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
